Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Vir Biotechnology Inc’s stock clocked out at $5.72, up 10.21% from its previous closing price of $5.19. In other words, the price has increased by $10.21 from its previous closing price. On the day, 2.53 million shares were traded. VIR stock price reached its highest trading level at $6.02 during the session, while it also had its lowest trading level at $4.95.
Ratios:
To gain a deeper understanding of VIR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.71 and its Current Ratio is at 8.71. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 03 ’25 when De Backer Marianne sold 79,712 shares for $5.95 per share. The transaction valued at 474,239 led to the insider holds 769,505 shares of the business.
Marianne De Backer bought 79,712 shares of VIR for $474,239 on Apr 03 ’25. On Feb 26 ’25, another insider, de Verneuil Vanina, who serves as the EVP and General Counsel of the company, sold 7,373 shares for $9.14 each. As a result, the insider received 67,402 and left with 79,460 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIR now has a Market Capitalization of 784457984 and an Enterprise Value of -42197464. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.57 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at -0.569 whereas that against EBITDA is 0.083.
Stock Price History:
The Beta on a monthly basis for VIR is 1.38, which has changed by -0.38095236 over the last 52 weeks, in comparison to a change of 0.049593568 over the same period for the S&P500. Over the past 52 weeks, VIR has reached a high of $14.45, while it has fallen to a 52-week low of $5.09. The 50-Day Moving Average of the stock is -29.18%, while the 200-Day Moving Average is calculated to be -31.91%.
Shares Statistics:
It appears that VIR traded 1.48M shares on average per day over the past three months and 1517350 shares per day over the past ten days. A total of 136.96M shares are outstanding, with a floating share count of 87.46M. Insiders hold about 36.22% of the company’s shares, while institutions hold 51.29% stake in the company. Shares short for VIR as of 1741910400 were 7880284 with a Short Ratio of 5.32, compared to 1739491200 on 7670907. Therefore, it implies a Short% of Shares Outstanding of 7880284 and a Short% of Float of 9.35.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
